A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events

Oral non-steroidal anti-inflammatory drugs (NSAIDs) are known to be associated with an increased risk of bleeding. The NSAID, flurbiprofen, in the form of 8.75 mg lozenge or oromucosal spray is indicated for the symptomatic relief of sore throat. Despite the low dose as compared to alternative flurb...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhanda, Sandeep, Evans, Alison, Roy, Debabrata, Osborne, Vicki, Townsley, Adam, Coutinho, Graça, Kulasekaran, Anuradha, Shakir, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371335/
https://www.ncbi.nlm.nih.gov/pubmed/34421619
http://dx.doi.org/10.3389/fphar.2021.726141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371335/
https://www.ncbi.nlm.nih.gov/pubmed/34421619
http://dx.doi.org/10.3389/fphar.2021.726141

Ejemplares similares